Integrating Financial Coaching and Smoking Cessation Coaching
NYU Langone Health · with National Cancer Institute (NCI) · NCT05154669
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–100 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Phase 3
- Target enrollment
- 602
- US sites recruiting
- 1
- Study start
- December 8, 2022
- Record last updated
- May 4, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This study conduct a two-arm, parallel-group randomized controlled trial. The study will recruit and randomize 900 smokers (n=450 per arm) to either: (1) Control: Standard Smoking Cessation Counseling or (2) Intervention: Integrated Financial-Smoking Cessation Counseling.
Being studied: Financial counseling; Nicotine Replacement Therapy Agent - Patches; Nicotine Replacement Therapy Agent - Lozenges; Nicotine Replacement Therapy Agent - Gum
Conditions: Smoking
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- age ≥18 years,
- smokes ≥5 cigarettes per day,
- interested in receiving smoking and financial counseling,
- self-reported income below 200% of the current federal poverty level,
- New York City resident,
- speaks English or Spanish language (the interventions and measures have not been validated in other languages),
- able to provide informed consent, and
- does not have a representative who manages his/her funds.
Exclusion Criteria
- people who know a current past study participant (to avoid intervention contamination)
- People who have a medical contraindication to using nicotine replacement therapy:
- allergy to nicotine patch
- pregnancy or intention to become pregnant over the next 12 months
- breastfeeding
- heart attack in the past 2 months
- underlying arrhythmia
- ongoing or worsening angina.
Recruiting US locations
NYU Langone Health
New York, NY 10016
Site contact: Erin Rogers, DrPH · 646-501-2544 · erin.rogers@nyulangone.org
Study contacts (from the official record)
- Erin Rogers, DrPH · 646-501-2544 · erin.rogers@nyulangone.org
Similar studies in New York
All smoking & vaping studies in New York →- RecruitingHealthy volunteersEarly Phase 1
Sensory Tests of Cigarettes for Identification of Flavors in Current Daily Smoking Adults
Roswell Park Cancer Institute
- Location
- Buffalo, NY
- Eligibility basics
- Ages 21+
- RecruitingHealthy volunteers
Detection of Oral and Throat Cancers Using OralViome Cancer Testing System
Viome
- Location
- New York, NY
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Studying NMDA and Sigma-1 in Smoking Cessation Treatment (SUMMIT)
Axsome Therapeutics, Inc.
- Location
- Brooklyn, NY + 24 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2
A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse
Eli Lilly and Company
- Location
- Rochester, NY + 16 other US sites
- Eligibility basics
- Ages 18–75